Evidence map›Paper›PMID 29696556›Full record

ArticleEndocrine2018

Long-term effect of testosterone replacement therapy on bone in hypogonadal men with Klinefelter Syndrome.

N Tahani, L Nieddu, G Prossomariti, M Spaziani, S Granato, F Carlomagno, A Anzuini, A Lenzi, A F Radicioni, E Romagnoli

Abstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Guideline
  2. Clinical practice guidelines for the management of differences of sex development in Japan.Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology · 2026
    Review
  3. Review
  4. Article
  5. Bone quality in endocrine diseases: determinants and clinical relevance.Journal of endocrinological investigation · 2023
    Review
  6. Article
  7. Extra-Gonadal and Non-Canonical Effects of FSH in Males.Pharmaceuticals (Basel, Switzerland) · 2023
    Review
  8. Review
  9. Update on trabecular bone score.Archives of endocrinology and metabolism · 2022
    Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

N TahaniCentre for Rare Diseases, Policlinico Umberto I, Rome, Italy. natascia.tahani@uniroma1.it.
L NiedduFaculty of Economics, UNINT University for International Studies of Rome, Rome, Italy.
G ProssomaritiDepartment of Radiology, Sapienza University of Rome, Rome, Italy.
M SpazianiCentre for Rare Diseases, Policlinico Umberto I, Rome, Italy.
S GranatoCentre for Rare Diseases, Policlinico Umberto I, Rome, Italy.
F CarlomagnoCentre for Rare Diseases, Policlinico Umberto I, Rome, Italy.
A AnzuiniDepartment of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Rome, Italy.
A LenziDepartment of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Rome, Italy.
A F RadicioniCentre for Rare Diseases, Policlinico Umberto I, Rome, Italy.
E RomagnoliDepartment of Experimental Medicine, Section of Medical Pathophysiology, Food Science and Endocrinology, Sapienza University of Rome, Rome, Italy.
Sapienza University of Rome · ITPoliclinico Umberto I · ITUniversità degli Studi Internazionali di Roma · IT

Funding

Agenzia Italiana del Farmaco, Ministero della Salute MRAR08Q009
6 · The paper itself

Abstract

purposeTo assess different aspects of bone damage in untreated adult patients with Klinefelter Syndrome (KS) before and during testosterone replacement therapy (TRT).

methodsFifteen untreated hypogonadal men with KS and 26 control subjects (C) matched for age and BMI were recruited. Sex hormone levels were measured in all subjects. Lumbar spine (LS) and femoral (neck: FN and total hip: TH) bone mineral density (BMD), trabecular bone score (TBS), hip structure analysis (HSA) and fat measures (percentage of fat mass, android/gynoid ratio and visceral adipose tissue) were evaluated by DEXA. In KS patients, blood analysis and DEXA measurements were assessed at baseline and repeated yearly for three years during TRT.

resultsFat measures were significantly higher in KS than C (p < 0.01). In contrast, mean LS, FN and TH BMD were significantly reduced in KS compared to C (p < 0.01), while there was no difference in TBS. HSA revealed a significantly lower cortical thickness and significantly higher buckling ratio in KS compared to C at all femoral sites (p < 0.01). In KS patients, TRT significantly increased BMD at LS only, but did not improve TBS and HSA parameters. Fat measures were inversely associated with TBS values, and TRT did not influence this relationship.

conclusionsIn untreated hypogonadal men with KS, lumbar and femoral BMD was reduced, and femoral bone quality was impaired. Adiposity seemed to have a detrimental effect on lumbar bone microarchitecture, as indirectly evaluated by TBS. However, TRT failed to remedy these negative effects on bone.

Indexed as

Hormone Replacement TherapyAdultBone and BonesBone DensityCancellous BoneCase-Control StudiesFemurFemur NeckFollow-Up StudiesHumansHypogonadismKlinefelter SyndromeLumbar VertebraeMaleMiddle AgedTestosteroneTestosteroneBone mineral densityHip structural analysisKlinefelter syndromeTrabecular bone score

Identifiers

PMID29696556
OpenAlexW2802235090

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.